formulation21.jpg

Formulations

NATCO has over 30 years of expertise in formulating innovative dosage forms. NATCO today is leveraging on this expertise to go global by exporting finished dosage products to various regulated markets across the globe.

US
  • Ondansetron 4mg & 8mg Tablets
  • Anastrozole 1mg Tablets
  • Letrozole 2.5mg Tablets
  • Trihexyphenidyl 2mg & 5mg Tablets
  • Cholorquine Phosphate 250mg & 500mg Tablets
Canada
  • Ondansetron 4mg & 8mg Tablets
  • Citalopram 10mg, 20m, 40mg Tablets
  • Letrozole 1 mg tablets
Europe
  • Anastrozole 1mg Tablets

Porducts are manufactured in facilities approved by US FDA, Minsitry of Health Greece, Infarmed Portugal, German Health Authority Hamburg

Paragraph IV filings in US

Over the last few years NATCO started to leverage on its Intellectual property for successful filing of Paragraph IV filings in the US along with its partners. The following is the list of successful First To File projects:

  • -Lanthanum carbonate – Fosrenol®
  • -Lenalidomide – Revlimid®
  • Oseltamivir Phosphate - Tamiflu ®
  • Lapatinib – Tykerb®

Our other most significant filings include:

  • -Glatiramer Acetate – Copaxone®
  • -Lansoprazole - Prevacid ®